169 related articles for article (PubMed ID: 17056598)
21. PINCH1 is transcriptional regulator in podocytes that interacts with WT1 and represses podocalyxin expression.
Wang D; Li Y; Wu C; Liu Y
PLoS One; 2011 Feb; 6(2):e17048. PubMed ID: 21390327
[TBL] [Abstract][Full Text] [Related]
22. Enhanced podocyte vesicle transport in the nephrotic rat.
Tojo A; Hatakeyama S; Kinugasa S; Fukuda S; Sakai T
Med Mol Morphol; 2017 Jun; 50(2):86-93. PubMed ID: 28314927
[TBL] [Abstract][Full Text] [Related]
23. KANK deficiency leads to podocyte dysfunction and nephrotic syndrome.
Gee HY; Zhang F; Ashraf S; Kohl S; Sadowski CE; Vega-Warner V; Zhou W; Lovric S; Fang H; Nettleton M; Zhu JY; Hoefele J; Weber LT; Podracka L; Boor A; Fehrenbach H; Innis JW; Washburn J; Levy S; Lifton RP; Otto EA; Han Z; Hildebrandt F
J Clin Invest; 2015 Jun; 125(6):2375-84. PubMed ID: 25961457
[TBL] [Abstract][Full Text] [Related]
24. Impact of zinc fingers and homeoboxes 3 on the regulation of mesenchymal stem cell osteogenic differentiation.
Suehiro F; Nishimura M; Kawamoto T; Kanawa M; Yoshizawa Y; Murata H; Kato Y
Stem Cells Dev; 2011 Sep; 20(9):1539-47. PubMed ID: 21174497
[TBL] [Abstract][Full Text] [Related]
25. Podocyte endocytosis in the regulation of the glomerular filtration barrier.
Inoue K; Ishibe S
Am J Physiol Renal Physiol; 2015 Sep; 309(5):F398-405. PubMed ID: 26084928
[TBL] [Abstract][Full Text] [Related]
26. The FERM protein EPB41L5 regulates actomyosin contractility and focal adhesion formation to maintain the kidney filtration barrier.
Schell C; Rogg M; Suhm M; Helmstädter M; Sellung D; Yasuda-Yamahara M; Kretz O; Küttner V; Suleiman H; Kollipara L; Zahedi RP; Sickmann A; Eimer S; Shaw AS; Kramer-Zucker A; Hirano-Kobayashi M; Abe T; Aizawa S; Grahammer F; Hartleben B; Dengjel J; Huber TB
Proc Natl Acad Sci U S A; 2017 Jun; 114(23):E4621-E4630. PubMed ID: 28536193
[TBL] [Abstract][Full Text] [Related]
27. Inducible ATF3-NFAT axis aggravates podocyte injury.
Zhang H; Liang S; Du Y; Li R; He C; Wang W; Liu S; Ye Z; Liang X; Shi W; Zhang B
J Mol Med (Berl); 2018 Jan; 96(1):53-64. PubMed ID: 29038896
[TBL] [Abstract][Full Text] [Related]
28. Role of cathepsin L in idiopathic nephrotic syndrome in children.
Keisuke S; Kohei M; Takuji E; Tomoki M; Yuichi M; Rina O; Tsukasa T; Mitsuru O
Med Hypotheses; 2020 Aug; 141():109718. PubMed ID: 32289645
[TBL] [Abstract][Full Text] [Related]
29. Administration of pigment epithelium-derived factor (PEDF) reduces proteinuria by suppressing decreased nephrin and increased VEGF expression in the glomeruli of adriamycin-injected rats.
Fujimura T; Yamagishi S; Ueda S; Fukami K; Shibata R; Matsumoto Y; Kaida Y; Hayashida A; Koike K; Matsui T; Nakamura K; Okuda S
Nephrol Dial Transplant; 2009 May; 24(5):1397-406. PubMed ID: 19042927
[TBL] [Abstract][Full Text] [Related]
30. Attenuated ZHX3 expression serves as a potential biomarker that predicts poor clinical outcomes in breast cancer patients.
You Y; Ma Y; Wang Q; Ye Z; Deng Y; Bai F
Cancer Manag Res; 2019; 11():1199-1210. PubMed ID: 30787639
[TBL] [Abstract][Full Text] [Related]
31. ANGPTL4 promotes nephrotic syndrome by downregulating podocyte expression of ACTN4 and podocin.
Li Y; Xu Z; Deng H; Liu M; Lin X; Zhang M; Li G; Yue S; Gao X
Biochem Biophys Res Commun; 2023 Jan; 639():176-182. PubMed ID: 36495766
[TBL] [Abstract][Full Text] [Related]
32. Podocyte and endothelial cell injury lead to nephrotic syndrome in proliferative lupus nephritis.
Nawata A; Hisano S; Shimajiri S; Wang KY; Tanaka Y; Nakayama T
Histopathology; 2018 Jun; 72(7):1084-1092. PubMed ID: 29247494
[TBL] [Abstract][Full Text] [Related]
33. Loss of the transcription repressor ZHX3 induces senescence-associated gene expression and mitochondrial-nucleolar activation.
Igata T; Tanaka H; Etoh K; Hong S; Tani N; Koga T; Nakao M
PLoS One; 2022; 17(1):e0262488. PubMed ID: 35085309
[TBL] [Abstract][Full Text] [Related]
34. Genome-Wide Analysis of Wilms' Tumor 1-Controlled Gene Expression in Podocytes Reveals Key Regulatory Mechanisms.
Kann M; Ettou S; Jung YL; Lenz MO; Taglienti ME; Park PJ; Schermer B; Benzing T; Kreidberg JA
J Am Soc Nephrol; 2015 Sep; 26(9):2097-104. PubMed ID: 25636411
[TBL] [Abstract][Full Text] [Related]
35. Early changes in gene expression that influence the course of primary glomerular disease.
Clement LC; Liu G; Perez-Torres I; Kanwar YS; Avila-Casado C; Chugh SS
Kidney Int; 2007 Aug; 72(3):337-47. PubMed ID: 17457373
[TBL] [Abstract][Full Text] [Related]
36. Podocyte injury: the role of proteinuria, urinary plasminogen, and oxidative stress.
Raij L; Tian R; Wong JS; He JC; Campbell KN
Am J Physiol Renal Physiol; 2016 Dec; 311(6):F1308-F1317. PubMed ID: 27335373
[TBL] [Abstract][Full Text] [Related]
37. Calcineurin inhibitors ameliorate PAN-induced podocyte injury through the NFAT-Angptl4 pathway.
Shen X; Zhang Y; Lin C; Weng C; Wang Y; Feng S; Wang C; Shao X; Lin W; Li B; Wang H; Chen J; Jiang H
J Pathol; 2020 Nov; 252(3):227-238. PubMed ID: 32686149
[TBL] [Abstract][Full Text] [Related]
38. The Krüppel-like factor 15-NFATc1 axis ameliorates podocyte injury: a novel rationale for using glucocorticoids in proteinuria diseases.
Dou C; Zhang H; Ke G; Zhang L; Lian Z; Chen X; Zhao X; Chen Y; Li R; Ma J; Li Z; Lin T; Wang W; Ye ZM; Liang X; Shi W; Zhang B; Liu S
Clin Sci (Lond); 2020 Jun; 134(12):1305-1318. PubMed ID: 32478397
[TBL] [Abstract][Full Text] [Related]
39. Carboxymethyl lysine induces EMT in podocytes through transcription factor ZEB2: Implications for podocyte depletion and proteinuria in diabetes mellitus.
Kumar PA; Welsh GI; Raghu G; Menon RK; Saleem MA; Reddy GB
Arch Biochem Biophys; 2016 Jan; 590():10-19. PubMed ID: 26550927
[TBL] [Abstract][Full Text] [Related]
40. The glomerular permeability factors in idiopathic nephrotic syndrome.
Davin JC
Pediatr Nephrol; 2016 Feb; 31(2):207-15. PubMed ID: 25925039
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
